Citation only
via OpenAlex
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
Xin Han, Yan‐Ling Wu, Qiao Yang, Gang Cao
Pharmacology & Therapeutics · 2020 · ▲ 70 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.pharmthera.2020.107791
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Han, X., Wu, Y., Yang, Q., & Cao, G. (2020). Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. <em>Pharmacology & Therapeutics</em>. https://doi.org/10.1016/j.pharmthera.2020.107791
Vancouver
Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacology & Therapeutics. 2020. doi:10.1016/j.pharmthera.2020.107791.
BibTeX
@article{xin2020Peroxi,
title = {Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis},
author = {Xin Han and Yan‐Ling Wu and Qiao Yang and Gang Cao},
journal = {Pharmacology & Therapeutics},
year = {2020},
doi = {10.1016/j.pharmthera.2020.107791},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2022
Open access · CC-BY
TNF ‐α/ IFN ‐γ synergy amplifies senescence‐associated inflammation and SARS‐CoV ‐2 receptor expression via hyper‐activated JAK / STAT1
Elsevier eBooks 2013
Citation only
Obesity, Insulin Resistance, and Inflammaging
Frontiers in Immunology 2020
Open access · CC-BY
Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis
Archives of Medical Research 2007
Citation only
Liver Fibrosis and Chronic Viral Hepatitis
Molecular Aspects of Medicine 2018
Preprint · OA
Developmental pathways in the pathogenesis of lung fibrosis
Advances in pharmacology 2025
Citation only